0
Applied AI·April 23, 2026·1 min read

Novo's pill for kids; Altimmune’s $225M offering; Merck teams with Google Cloud

Share

Merck leaning on Google Cloud for drug discovery and manufacturing analytics is another data point that pharma’s moat is shifting from wet lab IP to model-ready data and infra. If you’re in life sciences and still treating cloud and AI partnerships as IT procurement instead of core R&D strategy, you’re already behind the curve operators are now setting.